192 related articles for article (PubMed ID: 69667)
21. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
Pellis NR; Tom BH; Kahan BD
J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
[No Abstract] [Full Text] [Related]
22. Differential antigen presentation in tumor immunity.
Schatten S; Drebin JA; Granstein RD; Greene MI
Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
[TBL] [Abstract][Full Text] [Related]
23. A time factor in the success or failure of immune rejection of transplanted tumors.
Vaage J
Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
[TBL] [Abstract][Full Text] [Related]
24. Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes.
Chapoval AI; Nelson H; Thibault C
J Immunol; 1995 Aug; 155(3):1296-303. PubMed ID: 7636196
[TBL] [Abstract][Full Text] [Related]
25. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
Chen PW; Kaba DS; Ananthaswamy HN
Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
[TBL] [Abstract][Full Text] [Related]
26. Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route.
Sato S; Qian JH; Kokudo S; Ikegami R; Suda T; Hamaoka T; Fujiwara H
J Immunol; 1988 Feb; 140(3):717-22. PubMed ID: 2448373
[TBL] [Abstract][Full Text] [Related]
27. Immunological activity of regional lymph nodes in tumor-bearing mice.
Barna BP; Deodhar SD
Cancer Res; 1979 Jul; 39(7 Pt 1):2711-7. PubMed ID: 312691
[TBL] [Abstract][Full Text] [Related]
28. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
Hostetler LW; Romerdahl CA; Kripke ML
Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
[TBL] [Abstract][Full Text] [Related]
29. Presence of suppressor cells in spleens of mice bearing a weakly immunogenic syngeneic tumor.
Gautam SC; Deodhar SD
Cancer Res; 1979 Aug; 39(8):2945-51. PubMed ID: 313243
[TBL] [Abstract][Full Text] [Related]
30. Enhanced syngeneic tumor destruction by in vivo inhibition of suppressor T cells using anti-I-J alloantiserum.
Perry LL; Benacerraf B; McCluskey RT; Greene MI
Am J Pathol; 1978 Aug; 92(2):491-506. PubMed ID: 307911
[TBL] [Abstract][Full Text] [Related]
31. Development of protective immunity against bacterial and viral infections in tumor-bearing mice coincident with suppression of tumor immunity.
Bonventre PF; Nickol AD; Ball EJ; Michael JG; Bubel HC
J Reticuloendothel Soc; 1982 Jul; 32(1):25-35. PubMed ID: 6290658
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen.
Carter RH; Drebin JA; Schatten S; Perry LL; Greene MI
J Immunol; 1983 Feb; 130(2):997-1002. PubMed ID: 6184410
[TBL] [Abstract][Full Text] [Related]
33. Induction of immune tolerance during administration of monoclonal antibody to L3T4 does not depend on depletion of L3T4+ cells.
Carteron NL; Wofsy D; Seaman WE
J Immunol; 1988 Feb; 140(3):713-6. PubMed ID: 2448372
[TBL] [Abstract][Full Text] [Related]
34. Differential ability of tumor-unique and cross-reactive antigen(s) on two murine hepatoma cell lines to induce Lyt-1+2- T cells responsible for in vivo protective immunity.
Shima J; Yoshioka T; Kosugi A; Ogata M; Fujiwara H; Hamaoka T; Ueda S; Kato S
Biken J; 1987 Mar; 30(1):1-8. PubMed ID: 2445335
[TBL] [Abstract][Full Text] [Related]
35. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells.
Ohnishi K; Bonavida B
J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977
[TBL] [Abstract][Full Text] [Related]
36. A role for endogenous IL-12 in tumor immunity: IL-12 is required for the acquisition of tumor-migratory capacity by T cells and the development of T cell-accepting capacity in tumor masses.
Uekusa Y; Gao P; Yamaguchi N; Tomura M; Mukai T; Nakajima C; Iwasaki M; Takeuchi N; Tsujimura T; Nakazawa M; Fujiwara H; Hamaoka T
J Leukoc Biol; 2002 Nov; 72(5):864-73. PubMed ID: 12429708
[TBL] [Abstract][Full Text] [Related]
37. Receptor sites for antigen-antibody complexes on cells derived from solid tumors: detection by means of antibody sensitized sheep erythrocytes labeled with technetium-99m.
Wood GW; Gillespie GY; Barth RF
J Immunol; 1975 Mar; 114(3):950-7. PubMed ID: 1089728
[TBL] [Abstract][Full Text] [Related]
38. Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells.
Gutstein NL; Wofsy D
J Immunol; 1986 Dec; 137(11):3414-9. PubMed ID: 3097122
[TBL] [Abstract][Full Text] [Related]
39. Quantitative studies on the transplantability of murine and human tumors into the brain and subcutaneous tissues of NCr/Sed nude mice.
Zietman AL; Suit HD; Ramsay JR; Silobrcic V; Sedlacek RS
Cancer Res; 1988 Nov; 48(22):6510-6. PubMed ID: 3052803
[TBL] [Abstract][Full Text] [Related]
40. T cell subset interactions in the regulation of syngeneic tumor immunity.
Perry LL; Greene MI
Fed Proc; 1981 Jan; 40(1):39-44. PubMed ID: 6450065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]